Trial intelligence / Profile preview

Sovodak plus ribavirin for hospitalized patients with mild to moderate COVID-19

IRCT20200328046886N1Phase 3Completed

Sponsor

Mazandaran University of Medical Sciences

Start

Mar 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1